McLaren Port Huron, part of McLaren Health Care and its statewide McLaren Stroke Network, has earned the Get With The Guidelines® Stroke GOLD PLUS distinction from the American Heart Association/American Stroke Association, an acknowledgement of its proficiency in its care for stroke patients by consistently achieving national quality measurements.
Additionally, McLaren Port Huron was listed on the AHA/ASA’s Honor Roll Elite for its prompt use of alteplase, a medication to dissolve stroke-causing blood clots, and Target: Type 2 Diabetes Honor Roll, which recognizes the program for providing the latest evidence-based care to diabetic stroke patients.
“With strokes being as serious and life-threatening as they are, patients want a hospital and stroke program capable of providing the level of care they need to potentially save their life,” says Eric Cecava, McLaren Port Huron President and CEO. “Meeting and exceeding these national standards gives our community a significant level of comfort in our program’s expertise, knowledge, and ability to provide the best possible outcome.”
Distinction levels are determined based on programs’ compliance with the most up-to-date, evidence-based treatment guidelines set by the AHA/ASA to improve the care and clinical outcomes of stroke patients. The GOLD PLUS level — the highest achievable level — is earned by complying with these guidelines for 24 or more consecutive months.
Part of the McLaren Stroke Network, McLaren Port Huron has routinely earned national recognition for its care, treatment, quality, and outcomes.
“We are fortunate to have the expertise and knowledge of many skilled clinical professionals, which directly results in a higher level of care for our patients and best possible outcomes,” said Dr. Aniel Majjhoo, an interventional neurologist and medical director of the McLaren Stroke Network. “Adhering to the established guidelines puts our patients and providers in a position for success, and ultimately more treated patients being safely discharged home.”
Stroke is the fifth leading cause of death and the leading cause of adult disability in the United States. Certified as a Primary Stroke Center by The Joint Commission, McLaren Port Huron’s unique program approach allows for 24/7 initial evaluations by an interventional neurologist for all suspected stroke patients and 24/7 neuro intensive care coverage.
To learn more about the stroke program at McLaren Port Huron, visit mclaren.org/mphstroke.
About McLaren Port Huron
McLaren Port Huron is a 186-bed non-profit hospital located in Port Huron, Michigan, with a strong history of providing quality, compassionate care to residents living in St. Clair and Sanilac counties. It has earned repeated recognition for both clinical excellence and patient safety from nationally renowned health care rating organizations. McLaren Port Huron provides a full range of services, including cardiovascular care, award-winning cancer services through the Karmanos Cancer Institute, orthopedic services, and general, bariatric and robotic-assisted surgeries. The hospital is nationally verified as a Level III Trauma Center and operates the busiest Emergency Department in St. Clair County. Other services include family birthing services and the only accredited sleep center in the region. In addition to its main campus in Port Huron, the hospital operates community health centers in Marysville, Yale, Lexington, and St. Clair. Learn more at mclaren.org/porthuron.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6.6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 13 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 490-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, one of only 53 National Cancer Institute-designated comprehensive cancer centers in the U.S. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org.